Literature DB >> 28490207

microRNA-124: a putative therapeutic target and biomarker for major depression.

Yogesh Dwivedi1.   

Abstract

Entities:  

Keywords:  Antidepressant; biomarker; depression; miR-124

Mesh：

Substances：

Year:  2017        PMID： 28490207     DOI： 10.1080/14728222.2017.1328501

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  15 in total

Review 1.  MicroRNAs in depression and suicide: Recent insights and future perspectives.

Authors:  Yogesh Dwivedi
Journal:  J Affect Disord       Date:  2018-07-24       Impact factor: 4.839

Review 2.  The important roles of microRNAs in depression: new research progress and future prospects.

Authors:  Chenggui Miao; Jun Chang
Journal:  J Mol Med (Berl)       Date:  2021-02-27       Impact factor: 4.599

Review 3.  Advances in novel molecular targets for antidepressants.

Authors:  Qingzhong Wang; Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-07-16       Impact factor: 5.067

4.  Elevated peripheral inflammation is associated with attenuated striatal reward anticipation in major depressive disorder.

Authors:  Kaiping Burrows; Jennifer L Stewart; Rayus Kuplicki; Leandra Figueroa-Hall; Philip A Spechler; Haixia Zheng; Salvador M Guinjoan; Jonathan B Savitz; T Kent Teague; Martin P Paulus
Journal:  Brain Behav Immun       Date:  2021-01-26       Impact factor: 19.227

Review 5.  The role of microRNAs in glucocorticoid action.

Authors:  Sally A Clayton; Simon W Jones; Mariola Kurowska-Stolarska; Andrew R Clark
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

6.  Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response.

Authors:  Duan Zeng; Shen He; Shunying Yu; Guanjun Li; Changlin Ma; Yi Wen; Yifeng Shen; Yimin Yu; Huafang Li
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-08       Impact factor: 2.570

Review 7.  The Progress in Diagnosis and Treatment of Exosomes and MicroRNAs on Epileptic Comorbidity Depression.

Authors:  Nian Wei; Haiqing Zhang; Jing Wang; Shen Wang; Wenbo Lv; Limei Luo; Zucai Xu
Journal:  Front Psychiatry       Date:  2020-05-12       Impact factor: 4.157

8.  Expression alteration of microRNAs in Nucleus Accumbens is associated with chronic stress and antidepressant treatment in rats.

Authors:  Weichen Song; Yifeng Shen; Yanhua Zhang; Sufang Peng; Ran Zhang; Ailing Ning; Huafang Li; Xia Li; Guan Ning Lin; Shunying Yu
Journal:  BMC Med Inform Decis Mak       Date:  2019-12-19       Impact factor: 2.796

9.  Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-based Therapy or Treatment as Usual in Patients with Depression, Anxiety, or Stress and Adjustment Disorders.

Authors:  Xiao Wang; Kristina Sundquist; Karolina Palmér; Anna Hedelius; A A Memon; Jan Sundquist
Journal:  Int J Neuropsychopharmacol       Date:  2018-06-01       Impact factor: 5.176

10.  miR-138 Increases Depressive-Like Behaviors by Targeting SIRT1 in Hippocampus.

Authors:  Cuixia Li; Feng Wang; Pei Miao; Libo Yan; Silin Liu; Xian Wang; Zuolin Jin; Zexu Gu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-09       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.